Cargando…
The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?
When oral dopaminergic medication falls short in the treatment of Parkinson’s disease, patients are left with motor response fluctuations and dyskinesias that may have a large impact on functioning in daily life. They may benefit from one of the currently available advanced treatments, namely deep b...
Autores principales: | Dijk, Joke M., Espay, Alberto J., Katzenschlager, Regina, de Bie, Rob M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592668/ https://www.ncbi.nlm.nih.gov/pubmed/32651333 http://dx.doi.org/10.3233/JPD-202104 |
Ejemplares similares
-
Advanced Care Planning in Parkinson's Disease: In-depth Interviews With Patients on Experiences and Needs
por: Kurpershoek, Elisabeth, et al.
Publicado: (2021) -
The why, what, where, when and how of goal-directed choice: neuronal and computational principles
por: Verschure, Paul F. M. J., et al.
Publicado: (2014) -
Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
por: van Poppelen, Daniël, et al.
Publicado: (2021) -
Data citation: what, when, why?
por: Lemberger, Thomas
Publicado: (2018) -
Stress urinary incontinence: What, when, why, and then what?
por: Magon, Navneet, et al.
Publicado: (2011)